Endocrine Disorders

  • James W. Jefferson
  • John R. Marshall
Part of the Critical Issues in Psychiatry book series (CIPS)


Several distinct clinical syndromes may be produced by the secretion of excess adrenal cortical hormones. Excessive production of the principal mineralocorticoid, aldosterone, results in clinical and chemical signs of aldosteronism, and adrenal virilism may result from excessive production of adrenal androgens. Neuropsychiatric changes are most prominently associated with an excess of the principal glucocorticoid, cortisol.


Thyroid Hormone Primary Hyperparathyroidism Grave Disease Parathyroid Adenoma Serum Calcium Level 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Addison T: On the Constitutional and Local Effects of Disease of the Supra-renal Capsules. London, S Highby, 1855.Google Scholar
  2. Agras S, Oliveau DC: Primary hyperparathyroidism and psychosis. Can Med Assoc J 91: 1366–1367, 1964.PubMedGoogle Scholar
  3. Anderson J: Psychiatric aspects of primary hyperparathyroidism. Proc R Soc Med 61: 1123–1124, 1968.PubMedGoogle Scholar
  4. Anthony D, Dippe S, Hofeldt FD, et al: Personality disorder and reactive hypoglycemia. Diabetes 22: 664–675, 1973.PubMedGoogle Scholar
  5. Asher R: Myxedematous madness. Br Med J 2: 555–562, 1949.PubMedGoogle Scholar
  6. Axelrod J: Neural and endocrine control of catecholamine biosynthesis. Proc Fourth Int Congr Endocrinol. Amsterdam, Excerpta Medica, 1973.Google Scholar
  7. Barnes VH, Greenberg AH, Owings J, et al: The effect of chlorodiazepoxide (Librium) on thyroid function and thyrotoxicosis. Johns Hopkins Med J 131: 298–300, 1972.PubMedGoogle Scholar
  8. Baron JM: Chlorodiazepoxide (Librium) and thyroid function tests. Br Med J 1:699, 1967..Google Scholar
  9. Beck HG: The hallucinations of myxedema. Med Times 54: 201–203, 1926.Google Scholar
  10. Beidelman B: Treatment of chronic hypoparathyroidism with probenecid. Metabolism 7: 690–698, 1958.Google Scholar
  11. Berardinelli G: Pseudo-hypoparathyroidism with decreased glucose tolerance and diabetes insipidus. Acta Endocrinol 7: 16–19, 1951.Google Scholar
  12. Berger H: Hypoglycemia: A perspective. Postgrad Med 57: 81–85, 1975.PubMedGoogle Scholar
  13. Bergeron R, Murphy R, Warren K: Acute pancreatitis, acute hyperparathyroidism and low magnesium syndrome: A case report. Lahey Clinic Bull 12: 186–190, 1961.Google Scholar
  14. Bernstein IC: A case of hypothyroidism presenting as a psychiatric illness. Psychosomatics 6: 215–216, 1965.PubMedGoogle Scholar
  15. Berry M: Studies of the unknown factors in duodenal ulcer: Hypoglycemia as a possible etiologic factor. Am J Gastroenterol 27: 31–34, 1957.Google Scholar
  16. Bessher PD, Gardiner AQ, Hedley AJ, et al: Psychosis after alteration of thyroid status. Psychol Med 1: 260–262, 1971.Google Scholar
  17. Bleuler M: Endocrinological medicine and psychiatry. Henry Ford Hosp Med 115: 309–317, 1967.Google Scholar
  18. Bluestone H: Hyperthyroidism masquerading as functional psychosis. Am Pract Digest Treat 8: 557–558, 1957.Google Scholar
  19. Blumberg AG, Klein DF: Chlorpromazine–procyclidine and imipramine: Affects on thyroid function in psychiatric patients. Clin Pharmacol Ther 10: 2350–2355, 1969.Google Scholar
  20. Borman MD, Schmallenberg HC: Suicide following cortisone treatment. JAMA 146: 337–338, 1951.Google Scholar
  21. The Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13: 694–698, 1972.Google Scholar
  22. Bovil D: A case of functional hypoglycemia-a medico-legal problem. Br JPsychiatry 123: 353–358, 1973.Google Scholar
  23. Boyd IH, Cleveland SE: Psychiatric symptoms masking an insulinoma. Dis New Syst 28: 457–458, 1967.Google Scholar
  24. Boyd JD, Malgram JE, Stearns G: Clinical hyperparathyroidism. JAMA 93: 684–688, 1929.Google Scholar
  25. Brewer C: Psychosis due to acute hypothyroidism during the administration of carbimazole. Br J Psychiatry 115: 1181–1183, 1969.PubMedGoogle Scholar
  26. Bronsky D: Idiopathic hypoparathyroidism and pseudohypoparathyroidism. Medicine 37: 317–352, 1958.PubMedGoogle Scholar
  27. Browning TB, Atkins RW, Weiner H: Cerebral metabolic disturbances in hypothyroidism. Arch Intern Med 93: 938–950, 1954.Google Scholar
  28. Brownlie BE, Chambers ST, Sadler WA, et al: Lithium–associated thyroid disease A report of 14 cases of hypothyroidism and 4 cases of thyrotoxicosis. Aust NZ J Med 6: 223–229, 1976.Google Scholar
  29. Burch EA, Messervy PW: Psychiatric symptoms in medical illness: Hyperthyroidism revisited. Psychosomatics 19: 71–75, 1978.PubMedGoogle Scholar
  30. Burman KD, Cunningham EJ, Klachko DM, et al: Factitious hypoglycemia. Am J Med Sci 263: 23–30, 1973.Google Scholar
  31. Burns TW, Bregand R, van Deenen HJ, et al: Observations on blood glucose concentrations of human subjects during continuous sampling. Diabetes 14: 186–193, 1965.PubMedGoogle Scholar
  32. Bursten B: Psychoses associated with thyrotoxicosis. Arch Gen Psychiatry 4: 267–273, 1961.PubMedGoogle Scholar
  33. Cahil GF, Soeldner JS: A non–editorial on nonhypoglycemia. N Eng J Med 291: 905–906, 1974.Google Scholar
  34. Camp JD: Symmetrical calcification of cerebral basal ganglia. Radiology 49:568–577, 1947. Carmen JC, Wyatt RJ: Use of calcitonin in psychotic agitation or mania. Arch Gen Psychiatry 36: 72–75, 1979.Google Scholar
  35. Christensson TAT: Lithium, hypercalcaemia, and hyperparathyroidism. Lancet 2: 144, 1976.PubMedGoogle Scholar
  36. Christiansen C, Baastrup PC, Transbol I: Lithium, hypercalcaemia, hypermagnesaemia, and hyperparathyroidism. Lancet 2: 969, 1976.PubMedGoogle Scholar
  37. Clark F, Ormston BJ: Diazepam and tests of thyroid function. Br Med J 1: 585–586, 1971.PubMedGoogle Scholar
  38. Clark LD, Bauer W, Cobb S: Preliminary observations on mental disturbances occurring in patients under therapy with cortisone and ACTH. N Eng J Med 256: 205–216, 1952.Google Scholar
  39. Clark LD, Quarton GC, Cobb S, et al: Further observations on mental disturbances associated with cortisone and ACTH therapy. N Eng J Med 249: 178–183, 1953.Google Scholar
  40. Cleghorn RA: Adrenocortical insufficiency: Psychological and neurologic observations. Can Med Assoc J 65: 449–454, 1951.PubMedGoogle Scholar
  41. Clower CG, Young AJ, Kepas D: Psychotic states resulting from disorders of thyroid function. Johns Hopkins Med J 124: 305–310, 1969.PubMedGoogle Scholar
  42. Conn JW: Functional hyperinsulinism. A common and well defined clinical entity amendable to medical management. J. Michigan State Med Soc 46: 451–457, 1947.Google Scholar
  43. Cooper AF, Schapiru K: Case report: Depression, catatonic stupors and EEG changes in hyperparathyroidism. Psychol Med 3: 509–515, 1973.PubMedGoogle Scholar
  44. Cope O: Hyperparathyroidism. Am J Surg 99: 394–398, 1967.Google Scholar
  45. Cronin AJ: The Citadel. V Gollancz Ltd, London, 1937.Google Scholar
  46. Cushing H: Basophil adenomas of the pituitary body and their clinical manifestations. Bull John Hopkins Hosp 50: 137–195, 1932.Google Scholar
  47. Davis PJ: Factors affecting the determination of the serum protein–bound iodine. Am J Med 40: 918–921, 1966.PubMedGoogle Scholar
  48. Denko J, Kaelbling T: The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand 38: 7–70, 1962.Google Scholar
  49. DeVos JA: Deafness in hypothyroidism. J Laryngol Otol 77: 390–392, 1963.Google Scholar
  50. Dysken MW, Halaris AE: Post–ECT asterixis associated with primary hyperparathyroidism. Am J Psychiatry 135: 1237–1238, 1978.PubMedGoogle Scholar
  51. Earle BV: Thyroid hormone and tricyclic anti–depressants in resistant depressions. Am J Psychiatry 126: 1667–1669, 1970.PubMedGoogle Scholar
  52. Easson WM: Myxedema with psychosis. Arch Gen Psychiatry 14:277–283, 1966Google Scholar
  53. Ebaugh FG, Drake FR: Neuropsychiatric-like symptomatology of Addison’s disease: A review. Am J Med Sci 234: 106–113, 1957.Google Scholar
  54. Eitinger L: Hyperparathyroidism with mental changes. Nord Med 14: 1581–1585, 1942.Google Scholar
  55. Engle GL, Margolin SG: Neuropsychiatric disturbances in internal disease. Arch Intern Med 70: 236–259, 1941.Google Scholar
  56. Evensen OK: Alimentary hypoglycemia after stomach operations and influence of gastric emptying on glucose tolerance curve. Acta Med Scand 126 (suppl): 1–4, 1942.Google Scholar
  57. Fabrykant M: The problem of functional hyperinsulinism or functional hypoglycemia attributed to nervous causes: I. Laboratory and clinical correlations. Metabolism 4: 469–479, 1955a.PubMedGoogle Scholar
  58. Fabrykant M: The problem of functional hyperinsulinism or functional hypoglycemia attributed to nervous causes: II. Dietary and neurogenic factors. Metabolism 4: 480–490, 1955b.PubMedGoogle Scholar
  59. Fajans SS: Hyperinsulinism, hypoglycemia, and glucagon secretion, in Thorn G, Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw Hill, 1977, pp 586–595.Google Scholar
  60. Falk WE, Mahnke MW, Poskanzer DC: Lithium prophylaxis of corticotropin–induced psychosis. JAMA 241: 1011–1012, 1979.PubMedGoogle Scholar
  61. Fawcett JA, Bunney WE: Pituitary adrenal function and depression. Arch Gen Psychiatry 16: 517–535, 1967.PubMedGoogle Scholar
  62. Federal Drug Administration: Suspected adverse reaction to drugs. #690101–083–00201. Fonseca OA, Calverley JR: Neurologic manifestations of hypoparathyroidism. Arch Intern Med 120: 202–206, 1967.Google Scholar
  63. Ford CV, Bray GA, Swerdloff RS: A psychiatric study of patients referred with a diagnosis of hypoglycemia. Am J Psychiatry 133: 290–294, 1976.PubMedGoogle Scholar
  64. Fourman P, Davis RH, Jones KH, et al: Parathyroid insufficiency after thyroidectomy: A review of 46 patients with a study of the effects of hypocalcemia on the electroencephalogram. Br J Surg 50: 608–619, 1963.PubMedGoogle Scholar
  65. Fourman P, Rawnsley K, Davis RH, et al: Effect of calcium on mental symptoms in partial parathyroid insufficiency. Lancet 2: 914–915, 1967.PubMedGoogle Scholar
  66. Freyberg RH, Traeger CH, Patterson M, et al: Problems of prolonged cortisone treatment for rheumatoid arthritis: Further investigations. JAMA 147: 1538–1543, 1951.Google Scholar
  67. Garfinkel PE, Ezrin C, Stancer HG: Hypothyroidism and hyperparathyroidism associated with lithium. Lancet 2: 331–332, 1973.PubMedGoogle Scholar
  68. Gatewood JW, Organ CH, Meade BT: Mental changes associated with hyperparathyroidism. Am J Psychiatry 132: 129–132, 1975.PubMedGoogle Scholar
  69. Gibson JG: Emotions and the thyroid gland: A critical appraisal. J. Psychosom Res 6: 93–116, 1962.PubMedGoogle Scholar
  70. Glaser GH: Psychotic reactions induced by corticotropin (ACTH) and cortisone. Psychosom Med 15: 280–291, 1953.PubMedGoogle Scholar
  71. Goldman R: The effect of ACTH on one case of periarteritis nodosa, in Mote JR (ed): Proceedings of the First Clinical ACTH Conference. Philadelphia, Blakiston, 1950, p 437.Google Scholar
  72. Goolker P, Schein J: Psychic effects of ACTH and cortisone. Psychosom Med 15: 589–613, 1953.PubMedGoogle Scholar
  73. Greene JA, Swanson LW: Psychosis in hypoparathyroidism: Report of five cases. Ann Intern Med 14: 1233–1236, 1941.Google Scholar
  74. Gregory R, Andersch M: The filterable calcium of blood serum. Am J Med Sci 110: 263–271, 1936.Google Scholar
  75. Groschel W, Kluge H, Zhalten W, et al: Vergleichende Untersuchungen zum elecktrolytye Rhalten im Serum bei liprophylzne zyklothymer Psychosen. Pharmakopsych-Euro-Psychopharmakol 7: 300–306, 1974.Google Scholar
  76. Gull WW: On a cretinoid state supervening in adult life in women. Trans Clin Soc London 7: 180–185, 1873.Google Scholar
  77. Gupta VP, Ehrlich GE: Organic brain syndrome in rheumatoid arthritis following corticosteroid withdrawal. Arthritis Rheum 19: 1333–1338, 1976.PubMedGoogle Scholar
  78. Hafken L, Leichter S, Reich T: Organic brain dysfunction as a possible consequence of postgastrectomy hypoglycemia. Am J Psychiatry 132: 1321–1324, 1975.PubMedGoogle Scholar
  79. Hall RW, Popkin MK, Kirkpatrick B: Tricyclic exacerbation of steroid psychoses. J Nery Ment Dis 166: 738–742, 1978.Google Scholar
  80. Hamadah K, Teggin AF: Haloperidol, thyrotoxicosis and neurotoxicity. Lancet 2: 1019–1020, 1974.PubMedGoogle Scholar
  81. Hansten PD: Drug Interactions. Philadelphia, Lea & Febiger, 1976, p 271.Google Scholar
  82. Harris S: Hyperinsulinism and dysinsulinism. JAMA 83: 729–733, 1924.Google Scholar
  83. Hermann HT, Quarton GC: Psychological changes and psychogenesis in thyroid hormone disorders. J Clin Endocrinol 25: 327–338, 1965.Google Scholar
  84. Herridge CF, Abey-Wickrama I: Acute iatrogenic hypothyroid psychosis. Br Med J 3: 154, 1969.PubMedGoogle Scholar
  85. Hoefer PFA, Glaser GH: Effects of pituitary adrenocorticotrophic hormone (ACTH) therapy. JAMA 143: 620–622, 1950.Google Scholar
  86. Hofeldt FD: Reactive hypoglycemia. Metab Clin Exp 24: 1193–1208, 1975.PubMedGoogle Scholar
  87. Hoffman WC, Lewis RA, Thorn GW: Electroencephalogram in Addison’s disease. John HopkinsHosp Bull 70: 335–361, 1942.Google Scholar
  88. Hoffman WH, Chodoroff G, Piggott LR: Haloperidol and thyroid storm. Am J Psychiatry 135: 484–486, 1978.PubMedGoogle Scholar
  89. Hollister LE: Clinical Pharmacology of Psychotherapeutic Drugs. New York, Churchill Livingstone, 1978.Google Scholar
  90. Hullen RP: Magnesium, in Johnson FN (ed): Lithium Research and Therapy. New York, Academic Press, 1975, pp 369–372.Google Scholar
  91. Hurxthal LM, O’Sullivan JB: Cushing’s syndrome: Clinical differential diagnosis and complications. Ann Intern Med 51: 1–16, 1959.PubMedGoogle Scholar
  92. Ingbar SH, Waeber KA: Diseases of the thyroid, in Thorn G. Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw–Hill, 1977, pp 501–508.Google Scholar
  93. Jain VK: A psychiatric study of hypothyroidism. Psychiatr Clin 5: 121–130, 1972.Google Scholar
  94. Jefferson JW, Greist JH: Primer of Lithium Therapy. Baltimore, Williams & Wilkins, 1977.Google Scholar
  95. Josefson AM, MacKeanzie TB: Appearance of manic psychosis following rapid normalization of thyroid status. Am J Psychiatry 136: 846–847, 1979.Google Scholar
  96. Kates AG, Beall N, Bagor GF, et al: Sleep studies in asthmatic adults: Relationship of attacks to sleep stage and time of night. J Allergy 41: 164–173, 1968.Google Scholar
  97. Karpati G, Frame B: Neuropsychiatric disorders of primary hyperparathyroidism. Arch Neural 10: 387–397, 1964.Google Scholar
  98. Kind H: Psychische Stroungen bei Hyperparathyreoidismus. Arch Psychiatr Nervenkr 200: 1–11, 1959.Google Scholar
  99. Kleinschmidt HJ, Waxenberg SE, Cuker R: Psychophysiology and psychiatric management of thyrotoxicosis: A two-year follow-up study. J Mt Sinai Hosp 23: 131–153, 1956.Google Scholar
  100. Krieger DT, Gewirtz GP: Recovery of hypothalamic-pituitary-adrenal function, growth hormone responsiveness and sleep EEG pattern in a patient following removal of an adrenocortical adenoma. J Clin Endocrinol 38: 1075–1078, 1974.Google Scholar
  101. Lackey FH: Non-activated (apathetic) type of hyperthyroidism. N Eng J Med 294: 747–748, 1931.Google Scholar
  102. Lake CR, Fann WE: Possible potentiation of haloperidol neurotoxicity in acute hyperthyroidism. Br J Psychiatry 123: 523–525, 1973.PubMedGoogle Scholar
  103. Leggett J, Favazza AR: Hypoglycemia: An overview. J Clin Psychiatry 39:51–57, 1978. Levine R: Hypoglycemia. JAMA 230: 462–463, 1974.Google Scholar
  104. Lidz T: Emotional factors in the etiology of hyperthyroidism. Psychosom Med 11: 2–8, 1949.PubMedGoogle Scholar
  105. Lidz T, Carter JD, Lewis BI, et al: Effects of ACTH and cortisone on mood and mentation. Psychosom Med 14: 363–377, 1952.PubMedGoogle Scholar
  106. Lindstedt G, Nilsson L, Walinder J, et al: On the prevalence, diagnosis, and management of lithium–induced hypothyroidism in psychiatric patients. Br J Psychiatry 130: 452–458, 1977.PubMedGoogle Scholar
  107. Logothetis J: Psychotic behavior as the initial indicator of adult myxedema. J. Nery Ment Dis 136: 561–568, 1963.Google Scholar
  108. McConnell RJ, Menendez CE, Smith FR, et al: Defects of taste and smell in patients with hypothyroidism. Am J Med 59: 354–364, 1975.PubMedGoogle Scholar
  109. MacCrimmon DJ, Wallace JE, Goldberg W, et al: Emotional disturbance and cognitive deficits in hyperthyroidism. Psychosom Med 41: 331–340, 1979.PubMedGoogle Scholar
  110. Malden M: Hypothermic coma in myxedema. Br Med J 2: 764–765, 1955.PubMedGoogle Scholar
  111. Mazzaferri EL, Skillman EG: Diazepam (Valium) and thyroid function: A double blind, placebo controlled study in normal volunteers showing no drug effect. Am J Med Sci 248: 129–132, 1964.Google Scholar
  112. Merimee TJ: Spontaneous hypoglycemia in man. Adv Intern Med 22: 301–317, 1977.PubMedGoogle Scholar
  113. Michael RR, Gibbons JL: Interrelationships between the endocrine system and neuropsychiatry, in Pfeiffer CC, Smythies JR (eds): International Review of Neurobiology. New York, Academic Press, 1963, vol 5, pp 243–302.Google Scholar
  114. Mikkelsen EJ, Reider AA: Post–parathyroidectomy psychosis: Clinical and research implications. J Clin Psychiatry 40: 352–357, 1979.PubMedGoogle Scholar
  115. Mills IH: Clinical Aspects of Adrenal Function. Philadelphia, FA Davis, 1964.Google Scholar
  116. Noble P: Depressive illness and hyperparathyroidism. Proc R Soc Med 67: 1066–1067, 1974.PubMedGoogle Scholar
  117. Olivarus B. de F., Roder E: Reversible psychosis and dementia in myxoedema. Acta Psychiatr Scand 46: 1–13, 1970.Google Scholar
  118. Park S: Enhancement of anti-psychotic effect of chlorpromazine with L-triiodothyronine, in Prange AJ (ed): The Thyroid Axis, Drugs and Behavior. New York, Raven Press, 1974, pp 75–86.Google Scholar
  119. Permutt MA; Postprandial hypoglycemia. Diabetes 25: 719–733, 1976.PubMedGoogle Scholar
  120. Petersen P: Psychiatric disorders and primary hyperparathyroidism. JClin Endocrinol 28: 1491–1495, 1968.Google Scholar
  121. Pitts FN, Guze SB: Psychiatric disorders and myxedema. Am J Psychiatry 118:142–147, 1961. Post JT: Hypothyroid deafness. A clinical study of sensorineural deafness associated with hypothyroidism. Laryngoscope 74: 221–224, 1964.Google Scholar
  122. Potts JT, Roberts B: Significance of magnesium deficiency and its relation to parathyroid disease. Am J Med Sci 235: 206–219, 1958.PubMedGoogle Scholar
  123. Prange AJ, Jr, Wilson IC, Knox A, et al: Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications. Am J Psychiatry 127: 191–199, 1970.PubMedGoogle Scholar
  124. Prange AJ, Jr, Wilson IC, Breese GR, et al: Hormonal alteration of imipramine response: A review, in Sacher EJ (ed): Hormones, Behavior, and Psychopathology. New York, Raven Press, 1976, pp 41–67.Google Scholar
  125. Quarton GC, Clark LD, Cobb S, et al: Mental disturbances associated with ACTH and cortisone: A review of explanatory hypotheses. Medicine 34: 13–50, 1955.PubMedGoogle Scholar
  126. Reinfrank RF: Primary hyperparathyroidism with depression. Arch Intern Med (Chicago) 108: 606–610, 1961.Google Scholar
  127. Reus VI, Gold T, Post R: Lithium–induced thyrotoxicosis. Am J Psychiatry 136: 724–725, 1979.PubMedGoogle Scholar
  128. Robbins LR, Vinson DB: Objective psychological assessment of the thyrotoxic patient and the response to treatment: Preliminary report. J Clin Endocrinol 20: 120–129, 1960.Google Scholar
  129. Rome HP, Braceland FJ: The psychological response to ACTH, cortisone, hydrocortisone, and related steroid substances. Am J Psychiatry 108: 641–651, 1952.PubMedGoogle Scholar
  130. Rosser R: Thyrotoxoicosis and lithium. Br J Psychiatry 128: 61–66, 1976.PubMedGoogle Scholar
  131. Sacher EJ: Psychiatric disturbances associated with endocrine disorders, in Arieti S (ed): The American Handbook of Psychiatry, ed 2. New York, Basic Books, 1975, vol 4, pp 300–303.Google Scholar
  132. Sasenbach W, Madison L, Eisenberg S, et al: The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 33: 1444–1450, 1954.Google Scholar
  133. Scheinberg, Stead EA, Brannon ES, et al: Correlative observations on cerebral metabolism and cardiac output in myxedema. J Clin Invest 29: 1139–1146, 1950.PubMedGoogle Scholar
  134. Schon M, Sutherland AM, Rawson RW: Hormones and neurosis—the psychological effects of thyroid deficiency. Proc Third World Cong Psychiatr 2: 835–839, 1961.Google Scholar
  135. Schussler GC: Diazepam competes with thyroxine binding sites. J Pharmacol Exp Ther 178: 204–207, 1971.Google Scholar
  136. Selye H, Szabo S: Protection against haloperidol by catatoxic steroids. Psychopharmacol 24: 430–434, 1972.Google Scholar
  137. Siegal FP: Lithium for steroid–induced psychosis. N Eng J Med 299: 155–156, 1978.Google Scholar
  138. Singer FR, Bethune JE, Massry SG: Hypercalcemia and hypocalcemia. Clin Nephrol 7: 154–162, 1977.PubMedGoogle Scholar
  139. Smith CK, Barrish J, Correa J, et al: Psychiatric disturbance in endocrinologic disease. Psychosom Med 34: 69–86, 1972.PubMedGoogle Scholar
  140. Snowdon JA, MacFie AC, Pearce JB: Hypocalcaemic myopathy with paranoid psychosis. J Neuro Neurosurg Psychiat 39: 448–452, 1976.Google Scholar
  141. Sorkin SZ: Addison’s disease. Medicine 28: 371–425, 1949.PubMedGoogle Scholar
  142. Sparagana M, Rubnitz ME: Hypoglycemia presenting with neuropsychiatric symptoms. Postgrad Med 51: 192–196, 1972.Google Scholar
  143. Spillane JD: Nervous and mental disorders in Cushing’s syndrome. Brain 74: 72–94, 1951.PubMedGoogle Scholar
  144. Starr AM: Personality changes in Cushing’s syndrome. J Clin Endocrinol 12: 502–505, 1952.Google Scholar
  145. Thomas FB, Mazzaferri EL, Skillman TG: Apathetic thyrotoxicosis: A distinctive clinical and laboratory entity. Ann Intern Med 72: 679–685, 1970.PubMedGoogle Scholar
  146. Tonks CM: Mental illnesses in hypothyroid patients. Br J Psychiatry 110: 706–710, 1964.PubMedGoogle Scholar
  147. Treadway CR, Prange A), Jr, Doehne EF, et al: Myxedema psychosis: Clinical and biochemical changes during recovery. J Psychiatr Res 5: 289–296, 1967.PubMedGoogle Scholar
  148. Trethowan WH, Cobb S: Neuropsychiatric aspects of Cushing’s syndrome. Arch Neurol Psychiatry 67: 283–309, 1952.Google Scholar
  149. Uitert RV, Russakoff LM: Hyperthyroid chorea mimicking psychiatric disease. Am J Psychiatry 136: 1208–1210, 1979.PubMedGoogle Scholar
  150. Von Jauregg JW: Myxedema and cretinism, in Aschaffenburg G (ed): Handbuch der Psychiatrie. Leipzig and Vienna, F Deutiche, 1912, vol 2, p 12.Google Scholar
  151. Voth HM, Holzman PS, Kats JB, et al: Thyroid hot spots: Their relationship to life stress. Psychosom Med 32: 561–580, 1970.PubMedGoogle Scholar
  152. Ward DJ, Rasta11 ML: Prognosis in “myxedematous madness.” Br JPsychiatry 113: 149–151, 1967.Google Scholar
  153. Weiner MF: Haloperidol, hyperthyroidism, and sudden death. Am J Psychiatry 136: 717–718, 1979.PubMedGoogle Scholar
  154. Weinberg AD, Katzell TD: Thyroid and adrenal function among psychiatric patients. Lancet 1: 1104–1105, 1977.PubMedGoogle Scholar
  155. Wheatley D: Potentiation of amitriptyline by thyroid hormone. Arch Gen Psychiatry 26: 229–231, 1972.PubMedGoogle Scholar
  156. Whelton MJ, Samols E, Williams HS, et al: Factitious hypoglycemia in the diabetic, metabolic studies and diagnosis with radioisotopes. Metab Clin Exp 17: 923–927, 1968.PubMedGoogle Scholar
  157. Whipple AO: Hyperinsulinism in relation to pancreatic tumor. Surgery 16: 289–293, 1944.Google Scholar
  158. Whybrow PC, Prange AJ, Treadway CR: Mental changes accompanying thyroid gland dysfunction. Arch Gen Psychiatry 20: 48–63, 1969.PubMedGoogle Scholar
  159. Wilder RM: Clinical Diabetes Mellitus and Hyperinsulinism. Philadelphia, Saunders, 1941.Google Scholar
  160. Wilder RM, Allan FN, Power MH, et al: Carcinoma and islands of pancreas: Hyperinsulinism and hypoglycemia. JAMA 89: 348–350, 1927.Google Scholar
  161. Williams GH, Dluhy RG, Thorn GW, et al: Diseases of the adrenal cortex, in Thorn G. Adams RD, Braunwald E, et al (eds): Harrison’s Principles of Internal Medicine, ed 8. New York, McGraw Hill, 1977, pp 520–556.Google Scholar
  162. Williams RH: The pancreas, in Williams RH (ed): Textbook of Endocrinology. Philadelphia, Saunders, 1968, pp 613–802.Google Scholar
  163. Wilson I, Prange AJ, McClane TK, et al: Thyroid–hormone enhancement of imipramine in nonretarded depressions. N Eng J Med 282: 1063–1067, 1970.Google Scholar
  164. Wilson WP, Johnson JE, Feist FW: Thyroid hormone and brain function: II. Changes in photically elicited EEG responses following the administration of triiodothyronine to normal subjects. Electroencephalogr Clin Neurophysiol 16: 329–331, 1964.Google Scholar
  165. Woodbury DM: Relation between the adrenal cortex and the central nervous system. PharmacolRev 10: 275–357, 1958.Google Scholar
  166. Yager J, Young RT: Non–hypoglycemia in an epidemic condition. N Eng J Med 291: 907–908, 1974.Google Scholar
  167. Yosselson S, Kaplan A: Neurotoxic reaction to haloperidol in a thyrotoxic patient. N Engl J Med 293: 201, 1975.PubMedGoogle Scholar
  168. Zieve L, Jones DG, Aziz MA: Functional hypoglycemia and peptic ulcer. Postgrad Med 40: 159–170, 1966.PubMedGoogle Scholar
  169. Zivin I: The neurological and psychiatric aspects of hypoglycemia. Dis New Syst 31: 604–607, 1970.Google Scholar

Copyright information

© Plenum Publishing Corporation 1981

Authors and Affiliations

  • James W. Jefferson
    • 1
  • John R. Marshall
    • 1
  1. 1.University of Wisconsin Medical SchoolMadisonUSA

Personalised recommendations